Skip to content
OpenCapital
Get started

Bionano Genomics, Inc. BNGO Q4 2025 Annual earnings

Reported March 23, 2026 · After market close

Revenue$8.0MBeat by $71.5K
EPS-$0.03Beat by $0.78
Revenue estimate$7.9M
EPS estimate-$0.81

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$7.6M
EPS estimate-$0.70

Versus estimates

Revenue

Q1 2026$6.7MBeat by $119.5K
Q4 2025$8.0MBeat by $71.5K
Q3 2025$7.4MMiss by $533.0KQ2 2025$6.7MMiss by $489.5KQ1 2025$6.5MBeat by $207.0KQ4 2024$8.2MBeat by $2.0M

Diluted EPS

Q1 2026-$0.76Beat by $0.05
Q4 2025-$0.03Beat by $0.78
Q3 2025-$1.59Beat by $0.22Q2 2025-$1.99Beat by $0.70Q1 2025-$1.15Beat by $2.34Q4 2024-$57.49Miss by $51.49

Ask the moment Bionano Genomics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bionano Genomics, Inc. report Q4 2025 earnings?
Bionano Genomics, Inc. (BNGO) reported Q4 2025 earnings on March 23, 2026 after market close.
What were Bionano Genomics, Inc.'s Q4 2025 revenue and EPS?
Bionano Genomics, Inc. reported revenue of $8.0M and eps of $-0.03 for Q4 2025.
Did Bionano Genomics, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $7.9M by $71.5K. EPS beat the consensus estimate of $-0.81 by $0.78.
How did Bionano Genomics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 2.6% from $8.2M a year earlier and eps grew 99.9% from $-57.49.
Where can I find Bionano Genomics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001411690-26-000006) and the 10-K periodic report (0001411690-26-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.